logo
ProjectForthcoming

EURL for Hepatitis A virus and Hepatitis E virus

The status, timeline and source of this project. A free account opens every field.

Source: EU Funding & Tenders Portal

Hepatitis A and E viruses (HAV and HEV) represent significant cross-border public health challenges in Europe. The EU population is largely susceptible to hepatitis A virus (HAV) and is at constant risk of HAV-introduction from high-endemic countries. Hospitalization rates during outbreaks in the EU can exceed 50%. Hepatitis E virus (HEV) is the most common cause of acute hepatitis in the EU, caus

Status
Prospective
Sector
Government
Location
Norway, Germany, Netherlands
Updated
22 Jul 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about EURL for Hepatitis A virus and Hepatitis E virus

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “EURL for Hepatitis A virus and Hepatitis E virus” is an infrastructure initiative in the Government sector, located in Norway, Germany, Netherlands. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Sponsoring Agency

Status

Original status

forthcoming

Taiyo status

Prospective

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Hepatitis A and E viruses (HAV and HEV) represent significant cross-border public health challenges in Europe. The EU population is largely susceptible to hepatitis A virus (HAV) and is at constant risk of HAV-introduction from high-endemic countries. Hospitalization rates during outbreaks in the EU can exceed 50%. Hepatitis E virus (HEV) is the most common cause of acute hepatitis in the EU, causing asymptomatic to mild liver infection in immunocompetent individuals. HAV is notifiable, and diagnostics and typing are well established, but there is room for improvement, particularly in HAV typing methods. In comparison, HEV remains underdiagnosed with limited standardized diagnostics and is still not notifiable in many member states. The lack of harmonized molecular surveillance and coordinated data sharing hinders timely outbreak detection and effective response measures across the EU. The proposed EURL will assist disease network laboratories in establishing advanced diagnostic techniques, PCR, Sanger sequencing, and Whole Genome Sequencing (WGS), and provide robust reference diagnostics including molecular typing. Comprehensive surveys will assess current practices among disease network laboratories to identify gaps and inform the harmonization of protocols. Additionally, the development of customised External Quality Assessment (EQA) schemes, online tools and bioinformatics pipelines will support effective outbreak investigations and data sharing. The proposed EURL will serve as a central hub for providing reference diagnostics, technical support, and standardized protocols to disease network laboratories. It will coordinate the development and implementation of EQA schemes and facilitate the collection and analysis of high-quality WGS data, thereby strengthening the overall European laboratory surveillance framework for HAV and HEV.

Location

Country

Norway, Germany, Netherlands

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Government

Article published date

2026-01-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project